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Abstract	  	  1	  
Transketolase	  has	  significant	  industrial	  potential	  for	  the	  asymmetric	  synthesis	  of	  carbon-­‐carbon	  2	  
bonds	  with	  new	  chiral	  centres.	  	  Variants	  evolved	  on	  propanal	  were	  found	  previously	  with	  nascent	  3	  
activity	  on	  polar	  aromatic	  aldehydes	  3-­‐formylbenzoic	  acid	  (3-­‐FBA),	  4-­‐formylbenzoic	  acid	  (4-­‐FBA),	  and	  4	  
3-­‐hydroxybenzaldehyde	  (3-­‐HBA),	  suggesting	  a	  potential	  novel	  route	  to	  analogues	  of	  5	  
chloramphenicol.	  	  Here	  we	  evolved	  improved	  transketolase	  activities	  towards	  aromatic	  aldehydes,	  6	  
by	  saturation	  mutagenesis	  of	  two	  active-­‐site	  residues	  (R358	  and	  S385),	  predicted	  to	  interact	  with	  the	  7	  
aromatic	  substituents.	  	  S385	  variants	  selectively	  controlled	  the	  aromatic	  substrate	  preference,	  with	  8	  
up	  to	  13-­‐fold	  enhanced	  activities,	  and	  KM	  values	  comparable	  to	  those	  of	  natural	  substrates	  with	  wild-­‐9	  
type	  transketolase.	  	  S385E	  even	  completely	  removed	  the	  substrate	  inhibition	  for	  3-­‐FBA,	  observed	  in	  10	  
all	  previous	  variants.	  	  The	  mechanisms	  of	  catalytic	  improvement	  were	  both	  mutation	  type	  and	  11	  
substrate	  dependent.	  	  S385E	  improved	  3-­‐FBA	  activity	  via	  kcat,	  but	  reduced	  4-­‐FBA	  activity	  via	  KM.	  	  12	  
Conversely,	  S385Y/T	  improved	  3-­‐FBA	  activity	  via	  KM	  and	  4-­‐FBA	  activity	  via	  kcat.	  	  This	  suggested	  that	  13	  
both	  substrate	  proximity	  and	  active-­‐site	  orientation	  are	  very	  sensitive	  to	  mutation.	  	  Comparison	  of	  14	  
all	  variant	  activities	  on	  each	  substrate	  indicated	  different	  binding	  modes	  for	  the	  three	  aromatic	  15	  
substrates,	  supported	  by	  computational	  docking.	  	  This	  highlights	  a	  potential	  divergence	  in	  the	  16	  
evolution	  of	  different	  substrate	  specificities,	  with	  implications	  for	  enzyme	  engineering.	  17	  
	  18	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1. Introduction	  26	  
	   Asymmetric	  carbon-­‐carbon	  bond	  formation	  is	  a	  powerful	  method	  in	  organic	  synthesis	  [1-­‐8]	  27	  
and	  new	  routes	  could	  provide	  access	  to	  a	  wide	  range	  of	  novel	  and	  natural	  compounds	  that	  serve	  as	  28	  
building	  blocks	  for	  further	  synthesis	  [2].	  	  Enzymes	  such	  as	  transketolase	  (TK)	  (EC	  2.2.1.1)	  have	  been	  29	  
shown	  to	  catalyse	  asymmetric	  carbon-­‐carbon	  bond	  formation	  with	  considerable	  synthetic	  potential	  30	  
due	  to	  their	  high	  selectivity	  and	  specificity	  [1-­‐4,	  9-­‐13].	  	  TK	  belongs	  to	  the	  thiamine	  diphosphate	  31	  
(ThDP)	  dependent	  enzyme	  family,	  and	  plays	  two	  crucial	  roles	  in	  the	  non-­‐oxidative	  pentose	  32	  
phosphate	  pathway	  and	  Calvin	  cycle	  [14].	  	  It	  catalyses	  the	  reversible	  transfer	  of	  a	  C2-­‐hydroxyketone	  33	  
group	  from	  a	  ketol	  donor	  such	  as	  ketose	  sugars,	  to	  an	  aldehyde	  [15-­‐17].	  	  TK-­‐catalysed	  reactions	  34	  
produce	  an	  α,α’-­‐dihydroxy	  ketone	  group	  which	  is	  found	  in	  a	  wide	  range	  of	  natural	  compounds	  such	  35	  
as	  carbohydrates	  and	  corticosteroids	  [18].	  	  Hydroxypyruvate	  has	  been	  extensively	  used	  as	  a	  ketol	  36	  
donor	  instead	  of	  the	  natural	  ketose	  sugar	  substrates,	  due	  to	  the	  production	  of	  carbon	  dioxide,	  which	  37	  
can	  drive	  the	  reaction	  to	  completion.	  	  The	  use	  of	  TK	  could	  provide	  advantages	  over	  chemical	  38	  
synthesis	  routes	  which	  tend	  to	  suffer	  from	  low	  yields	  due	  to	  multistep	  procedures	  [18]	  and	  racemic	  39	  
products	  or	  low	  stereoselectivities	  when	  a	  single	  step	  method	  is	  applied	  [19,	  20].	  	  So	  far,	  40	  
transketolases	  from	  several	  organisms	  have	  been	  exploited	  in	  new	  synthetic	  routes	  to	  carbohydrates	  41	  
and	  sugar	  analogues	  [21-­‐24],	  (+)-­‐exo-­‐brevicomin	  [25],	  N-­‐	  hydroxypyrrolidine	  [26],	  furaneol	  [27],and	  42	  
the	  glycosidase	  inhibitor	  1,4-­‐dideoxy-­‐1,4-­‐imino-­‐D-­‐arabinitol	  [28].	  By	  coupling	  a	  transaminase	  (TAm)	  43	  
step	  as	  a	  TK-­‐TAm	  pathway,	  chiral	  amino-­‐alcohols	  can	  also	  be	  synthesised	  enantioselectively	  [29].	  44	  
Extending	  the	  acceptance	  of	  this	  pathway	  to	  include	  aromatic	  aldehydes	  would	  open	  up	  routes	  to	  45	  
chiral	  aromatic	  amino-­‐alcohols	  such	  as	  chloramphenicol	  antibiotics,	  norephedrine,	  and	  also	  their	  46	  
analogues	  with	  alternative	  aromatic	  substituents.	  	  47	  
	   Although	  wild-­‐type	  transketolases	  can	  accept	  a	  wide	  range	  of	  aliphatic,	  aromatic,	  and	  cyclic	  48	  
aldehydes	  [8,	  17,	  21,	  23,	  30],	  short	  chain	  aliphatic	  aldehydes	  tend	  to	  give	  faster	  reactions	  than	  more	  49	  
sterically-­‐challenging	  substrates	  [21,	  23,	  30].	  	  In	  addition,	  most	  of	  the	  synthetic	  products	  previously	  50	  
reported	  used	  aliphatic	  hydroxylated	  aldehydes	  as	  starting	  materials.	  Expansion	  of	  the	  substrate	  51	  
4	  
	  
range	  accepted	  by	  transketolases	  will	  increase	  their	  potential	  use	  for	  the	  synthesis	  of	  novel	  52	  
dihydroxy	  ketone	  compounds.	  Indeed,	  protein	  engineering	  of	  WT	  E.	  coli	  TK	  has	  been	  successfully	  53	  
used	  to	  improve	  its	  activity	  towards	  aliphatic	  aldehydes	  [31],	  with	  both	  enhanced	  and	  reversed	  54	  
stereospecificity	  [32-­‐35],	  and	  also	  improved	  activity	  towards	  D-­‐ribose	  and	  D-­‐glucose	  [36].	  	  By	  55	  
contrast,	  aromatic	  aldehydes	  still	  suffer	  from	  low	  reaction	  yields	  [33],	  except	  3-­‐formylbenzoic	  acid	  56	  
(3-­‐FBA)	  and	  4-­‐formylbenzoic	  acid	  (4-­‐FBA)	  which	  introduce	  a	  beneficial	  binding	  interaction	  between	  57	  
their	  carboxylic	  acid	  group	  and	  the	  transketolase	  phosphate-­‐binding	  residues	  [37].	  	  The	  E.	  coli	  TK	  58	  
variant	  D469T	  was	  found	  previously	  to	  have	  the	  highest	  activity	  towards	  the	  carboxylated	  aromatic	  59	  
substrates	  3-­‐FBA	  and	  4-­‐FBA,	  from	  all	  TK	  variants	  tested	  [37].	  However,	  the	  best	  activity	  was	  still	  low	  60	  
compared	  to	  any	  natural	  substrates,	  and	  for	  3-­‐FBA,	  substrate	  inhibition	  was	  also	  always	  present.	  	  61	  
	   Saturation	  mutagenesis	  at	  residues	  that	  interact	  directly	  with	  substrates	  have	  the	  greatest	  62	  
potential	  to	  improve	  enzyme	  activity	  and	  stereospecificity	  in	  a	  single	  round	  of	  evolution,	  compared	  63	  
to	  mutation	  of	  residues	  at	  more	  distant	  locations	  [38].	  	  We	  have	  therefore	  applied	  a	  targeted	  64	  
saturation	  mutagenesis	  strategy	  to	  further	  improve	  the	  activity	  and	  yield	  towards	  the	  	  substituted	  65	  
benzaldehydes	  3-­‐FBA,	  4-­‐FBA	  and	  additionally,	  3-­‐hydroxybenzaldehyde	  (3-­‐HBA)	  (Scheme	  1).	  66	  
	  67	  
Scheme	  1.	  Aromatic	  aldehyde	  substrates	  and	  their	  respective	  products.	  68	  
5	  
	  
	   Previously,	  the	  variant	  D469T/R520Q	  was	  found	  to	  retain	  most	  of	  the	  activity	  of	  D469T,	  69	  
towards	  3-­‐FBA	  and	  4-­‐FBA.	  The	  saturation	  mutagenesis	  was	  targeted	  into	  D469T/R520Q,	  as	  it	  is	  also	  70	  
more	  readily	  able	  to	  accommodate	  further	  mutations	  due	  to	  stabilisation	  of	  the	  enzyme	  in	  terms	  of	  71	  
protection	  from	  the	  formation	  of	  insoluble	  aggregates	  [39].	  Residue	  S385	  is	  within	  one	  of	  two	  72	  
cofactor-­‐binding	  loops	  (residues	  383-­‐393)	  present	  in	  each	  active-­‐site	  of	  E.	  coli	  TK,	  and	  not	  structured	  73	  
in	  the	  apo-­‐enzyme	  [40].	  The	  side	  chain	  hydroxyl	  group	  of	  S385	  can	  form	  a	  hydrogen	  bond	  with	  the	  74	  
phosphate	  moiety	  of	  natural	  substrates,	  as	  determined	  from	  several	  E.	  coli	  TK	  crystal	  structures	  with	  75	  
substrates	  (2R5N,	  2R8O,	  2R8P)	  [41].	  Residue	  R358	  is	  also	  involved	  in	  binding	  the	  phosphate	  moiety	  76	  
of	  natural	  substrates	  [41],	  as	  confirmed	  by	  selected	  mutagenesis	  of	  the	  yeast	  TK	  at	  the	  equivalent	  77	  
site,	  such	  that	  R359A	  resulted	  in	  a	  2-­‐fold	  and	  38-­‐fold	  increase	  in	  KM	  for	  xylulose	  5-­‐phosphate	  and	  78	  
ribose	  5-­‐phosphate,	  respectively	  [42].	  	  Previous	  mutations,	  R358P	  and	  R358L	  also	  indicated	  an	  79	  
analogous	  interaction	  with	  the	  carboxylate	  moieties	  of	  3-­‐FBA	  and	  4-­‐FBA	  [37].	  In	  our	  previous	  work,	  80	  
saturation	  mutagenesis	  of	  S385	  and	  R358,	  along	  with	  18	  other	  sites	  within	  the	  wild-­‐type	  enzyme,	  81	  
aimed	  to	  improve	  activity	  towards	  non-­‐aromatic	  aldehydes,	  glycolaldehyde	  and	  propanal	  [31,	  43].	  82	  
While	  several	  other	  sites	  gave	  significantly	  improved	  activities,	  S385	  gave	  no	  variants	  of	  interest,	  and	  83	  
R358	  yielded	  only	  R358I	  with	  a	  2-­‐fold	  improvement	  of	  activity	  towards	  each	  substrate.	  Here,	  S385	  84	  
and	  R358	  have	  again	  been	  mutated	  to	  all	  possible	  amino	  acids,	  but	  within	  D469T/R520Q	  instead	  of	  85	  
wild-­‐type	  TK,	  resulting	  in	  improved	  activities	  towards	  substituted	  aromatic	  aldehydes.	  86	  
	  87	  
	  88	  
2. Materials	  and	  Methods	  89	  
2.1. Chemicals	  and	  reagents	  90	  
All	  chemical	  reagents	  were	  purchased	  from	  Sigma-­‐Aldrich	  (Aldrich®	  Chemistry,	  UK),	  91	  




2.2. Transketolase	  library	  94	  
Mutations	  were	  constructed	  on	  D469T/R520Q	  due	  to	  its	  stability	  [39],	  and	  initial	  activity	  on	  95	  
the	  aromatic	  aldehydes	  [37].	  The	  transketolase	  D469T/R520Q	  variant	  gene	  and	  all	  further	  variants	  96	  
were	  expressed	  under	  the	  control	  of	  tktA	  gene	  promoter	  in	  the	  plasmid	  pQR791	  in	  XL-­‐10	  Gold	  97	  
(Stratagene)	  [40].	  Target	  residues	  for	  saturation	  mutagenesis	  were	  from	  those	  determined	  to	  be	  in	  98	  
the	  first	  shell	  [43].	  Mutagenesis	  was	  targeted	  only	  to	  those	  involved	  in	  binding	  phosphate	  groups	  99	  
within	  natural	  substrates,	  as	  determined	  by	  previous	  mutagenesis	  and	  crystal	  structure	  analysis	  [41].	  	  100	  
These	  included	  S385,	  R358,	  H461	  and	  R520.	  R520	  was	  already	  mutated	  to	  R520Q	  in	  the	  parent	  101	  
variant	  D469T/R520Q,	  and	  so	  not	  mutated	  further.	  H461	  was	  also	  excluded	  from	  further	  mutation	  as	  102	  
it	  was	  previously	  found	  to	  lead	  to	  stability	  issues	  [37,39].	  	  Mutagenesis	  was	  carried	  out	  using	  103	  
Quikchange	  site	  directed	  mutagenesis	  (Stratagene).	  The	  dpnI-­‐digested	  PCR	  product	  was	  transformed	  104	  
into	  XL-­‐10	  gold	  competent	  cells	  (Stratagene).	  The	  quality	  and	  diversity	  of	  the	  PCR	  was	  checked	  by	  105	  
DNA	  sequencing	  prior	  to	  screening.	  The	  primers	  used	  for	  additional	  variant	  construction	  were	  listed	  106	  
below	  (codon	  underlined,	  mutations	  in	  bold,	  and	  N	  is	  an	  equal	  mix	  of	  all	  four	  bases,	  H	  is	  33%	  A,	  107	  
33%	  C	  and	  33%	  T,	  and	  S	  is	  50%	  G	  and	  50%	  C).	  108	  
R358X	   GAAAATCGCCAGCNHNAAAGCGTCTCAGAATG	  109	  
S385X	   GCTGACCTGGCGCCGNHSAACCTGACCCTGTGG	  110	  
The	  NHN	  and	  NHS	  codons	  both	  exclude	  Cys,	  Trp,	  Arg	  and	  Gly	  amino-­‐acids.	  111	  
	  112	  
2.3. Library	  Screening	  113	  
After	  the	  transformation,	  24	  colonies	  for	  each	  library	  were	  inoculated	  into	  12	  ml	  LB	  media	  114	  
with	  150	  μg/ml	  ampicillin,	  incubated	  for	  18	  hours	  at	  37	  °C,	  shaking	  at	  250	  rpm	  and	  then	  2	  ml	  of	  the	  115	  
culture	  was	  centrifuged	  at	  13000	  rpm	  for	  10	  minutes.	  The	  probability	  of	  coverage	  and	  possible	  116	  
number	  of	  amino	  acid	  replacements	  was	  calculated	  using	  the	  online	  tool:	  GLUE-­‐IT	  [44]	  (currently	  117	  
maintained	  at	  http://guinevere.otago.ac.nz/cgi-­‐bin/aef/glue-­‐IT.pl).	  	  From	  each	  codon	  mix	  used,	  the	  118	  
7	  
	  
two	  libraries	  could	  produce	  16	  possible	  variants	  and	  so	  11.6	  distinct	  amino	  acids	  were	  expected	  119	  
within	  24	  randomly	  picked	  colonies.	  The	  diversity	  of	  mutations	  was	  confirmed	  by	  DNA	  sequencing	  of	  120	  
at	  least	  6	  random	  colonies	  from	  each	  library.	  121	  
Cell	  pellets	  were	  resuspended	  in	  200	  μl	  of	  2x	  cofactor	  solution	  (4.8	  mM	  ThDP	  and	  18	  mM	  122	  
MgCl2	  in	  50	  mM	  Tris.HCl,	  pH	  7.0),	  incubated	  for	  20	  minutes,	  and	  150	  μl	  then	  transferred	  to	  a	  123	  
borosilicate	  microplate	  (Radleys,	  Essex,	  UK).	  Screens	  were	  performed	  on	  whole	  cells	  to	  avoid	  the	  124	  
influence	  of	  uneven	  cell	  disruption	  on	  TK	  release	  and	  the	  bioconversion	  rate.	  Final	  yields	  of	  products	  125	  
using	  whole	  cells	  and	  clarified	  lysates,	  were	  found	  to	  correlate	  well	  (supplementary	  information	  Figs.	  126	  
S1	  &	  S2).	  Reactions	  were	  started	  by	  the	  addition	  of	  150	  μl	  of	  2x	  substrate	  solution	  (100	  mM	  3-­‐FBA	  127	  
and	  100	  mM	  HPA,	  80	  mM	  4-­‐FBA	  and	  80	  mM	  HPA,	  or	  30	  mM	  3-­‐HBA	  and	  60	  mM	  HPA,	  each	  in	  50	  mM	  128	  
Tris	  buffer,	  pH	  7.0).	  All	  reactions	  were	  performed	  at	  22	  °C	  with	  shaking	  at	  200	  rpm,	  3	  mm	  amplitude,	  129	  
to	  avoid	  cell	  sedimentation,	  and	  sealed	  to	  prevent	  evaporation	  (Thermo	  Scientific	  Nunc).	  Conversion	  130	  
to	  product	  was	  determined	  in	  3-­‐FBA	  samples	  taken	  at	  1	  hour	  and	  24	  hours	  after	  the	  reaction	  was	  131	  
started.	  Conversion	  at	  1	  hour	  provided	  a	  comparison	  of	  activities,	  whereas	  conversion	  at	  24	  hours	  132	  
provided	  final	  product	  yields.	  For	  the	  slower	  reactions	  with	  4-­‐FBA	  and	  3-­‐HBA,	  the	  libraries	  were	  133	  
screened	  for	  conversion	  after	  18	  hours	  to	  identify	  variants	  with	  improved	  activities.	  134	  
At	  each	  time-­‐point,	  20	  μl	  of	  the	  reaction	  sample	  was	  added	  to	  380	  μl	  0.1%	  TFA,	  centrifuged	  135	  
at	  13000	  rpm	  for	  3	  mins,	  and	  supernatants	  analysed	  by	  HPLC	  with	  an	  ACE5	  C18	  reverse	  phase	  136	  
column	  (150x4.6	  mm).	  The	  3-­‐FBA	  and	  4-­‐FBA	  reaction	  samples	  were	  analysed	  as	  previously	  described	  137	  
[37]	  using	  two	  mobile	  phases	  0.1%	  TFA	  and	  100%	  acetonitrile,	  and	  a	  flow	  rate	  of	  1	  ml/min	  (see	  SI	  for	  138	  
further	  details).	  	  The	  3-­‐HBA	  reaction	  samples	  were	  analysed	  by	  gradient	  elution	  as	  follows.	  Using	  a	  139	  
mobile	  phase	  of	  0.2M	  acetic	  acid	  and	  80%	  methanol	  at	  the	  flow	  rate	  of	  1ml/min,	  the	  flow	  profile	  was	  140	  
separated	  into	  3	  phases:	  1st	  phase	  5	  mins	  using	  90%	  0.2	  M	  acetic	  acid/10%	  methanol	  (80%v/v);	  2nd	  141	  
phase	  ramped	  linearly	  to	  40%	  0.2	  M	  acetic	  acid/60%	  methanol	  (80%v/v)	  over	  14	  mins,	  and	  the	  last	  142	  
phase	  maintaining	  40%	  0.2	  M	  acetic	  acid/60%	  methanol	  (80%v/v)	  for	  6	  mins.	  The	  column	  was	  then	  143	  
8	  
	  
re-­‐equilibrated	  for	  3	  mins	  using	  90%	  0.2	  M	  acetic	  acid/10%	  methanol	  (80%v/v).	  The	  retention	  time	  144	  
of	  the	  product	  from	  the	  3-­‐HBA	  reaction	  was	  4.7	  min	  and	  that	  for	  3-­‐HBA	  was	  14.5	  min.	  145	  
	  146	  
2.4. Cell	  culture	  and	  protein	  quantification	  for	  detailed	  enzyme	  kinetics	  147	  
Glycerol	  stocks	  of	  selected	  variants	  were	  re-­‐streaked	  on	  150	  µg/ml	  ampicillin-­‐LB	  plates	  and	  148	  
incubated	  at	  37	  °C	  for	  18	  hours.	  Single	  colonies	  were	  inoculated	  into	  20	  ml	  LB	  with	  150	  µg/ml	  149	  
ampicillin	  in	  250	  ml	  shake	  flasks,	  incubated	  at	  37	  °C	  with	  shaking	  at	  250	  rpm	  for	  18	  hours,	  then	  150	  
harvested	  by	  centrifugation.	  Supernatant-­‐free	  cell	  pellets	  were	  resuspended	  in	  Tris	  buffer,	  pH	  7.0	  151	  
and	  sonicated	  on	  ice	  (MSE	  Soniprep	  150	  probe,	  Sanyo)	  with	  10s	  on,	  15s	  off	  for	  10	  cycles.	  Cell	  debris	  152	  
was	  removed	  by	  centrifugation	  at	  17,700	  g	  for	  10	  minutes	  at	  4	  °C.	  The	  clarified	  lysate	  was	  aliquotted	  153	  
and	  stored	  at	  -­‐80	  °C.	  Total	  protein	  concentration	  in	  the	  clarified	  lysate	  was	  determined	  using	  the	  154	  
Bradford	  assay	  with	  BSA	  as	  a	  standard	  protein.	  The	  lysate	  was	  further	  analysed	  by	  SDS-­‐PAGE	  and	  155	  
densitometry	  as	  previously	  described	  [43]	  to	  determine	  the	  TK	  concentration	  which	  was	  always	  156	  
over-­‐expressed	  to	  above	  20%	  of	  the	  total	  protein.	  The	  plasmids	  of	  these	  variants	  were	  extracted	  and	  157	  
sequenced	  to	  identify	  the	  mutation.	  	  The	  whole	  procedure	  was	  performed	  in	  triplicate	  for	  each	  158	  
variant.	  159	  
	  160	  
2.5. Detailed	  enzyme	  kinetics	  161	  
Detailed	  enzyme	  kinetic	  analyses	  were	  carried	  out	  on	  clarified	  lysates,	  as	  this	  is	  the	  form	  162	  
most	  relevant	  to	  industrial	  biocatalytic	  processes,	  either	  as	  an	  isolated	  enzyme	  or	  within	  a	  de	  novo	  163	  
pathway	  [45].	  TK	  enzyme	  purification	  has	  also	  previously	  led	  to	  instabilities	  that	  would	  affect	  the	  164	  
observed	  kinetics	  [39].	  Clarified	  lysates	  of	  the	  variants	  with	  high,	  moderate,	  and	  low	  enzyme	  165	  
activities	  or	  conversion	  yields,	  prepared	  as	  above,	  were	  used	  to	  determine	  their	  specific	  activities	  or	  166	  
yield	  towards	  each	  substrate.	  Variants	  with	  high	  activities	  towards	  at	  least	  one	  substrate	  were	  167	  
further	  studied	  to	  determine	  the	  KM	  and	  kcat	  for	  all	  the	  substrates.	  Kinetic	  parameters	  were	  obtained	  168	  
at	  saturating	  50	  mM	  HPA	  levels	  and	  the	  aldehyde	  concentrations	  varied	  (3-­‐FBA	  3	  to	  90	  mM,	  4-­‐FBA	  6	  169	  
9	  
	  
to	  30	  mM,	  3-­‐HBA	  5	  to	  25	  mM).	  Substrate	  solutions	  were	  prepared	  at	  3x	  in	  50	  mM	  Tris.HCl,	  pH	  7.0.	  170	  
To	  30	  µl	  of	  clarified	  lysate,	  30	  µl	  of	  10x	  cofactor	  solution	  (24	  mM	  ThDP,	  90	  mM	  MgCl2)	  was	  added	  171	  
with	  140	  µl	  50	  mM	  Tris.HCl,	  pH	  7.0,	  and	  incubated	  for	  20	  mins.	  Reactions	  were	  initiated	  by	  the	  172	  
addition	  of	  100	  μl	  of	  substrate	  solution.	  All	  reactions	  were	  carried	  out	  in	  triplicate	  in	  glass	  vials	  at	  173	  
22	  °C.	  To	  20	  μl	  of	  reaction	  samples,	  380	  μl	  of	  0.1%	  TFA	  was	  added	  and	  the	  mixture	  centrifuged	  at	  174	  
13,000	  rpm	  for	  3	  mins.	  The	  supernatants	  were	  analysed	  by	  HPLC	  as	  above.	  3-­‐FBA	  reaction	  samples	  175	  
were	  taken	  at	  every	  3	  mins	  for	  15	  mins.	  The	  reaction	  samples	  of	  4-­‐FBA	  were	  taken	  at	  15	  minute	  176	  
intervals	  for	  90	  mins.	  3-­‐HBA	  reaction	  samples	  were	  taken	  every	  30	  mins	  for	  180	  mins.	  Samples	  at	  177	  
18	  hours	  for	  the	  highest	  aldehyde	  concentrations	  were	  also	  taken	  to	  quantify	  the	  reaction	  yield	  178	  
determined	  from	  product	  concentrations.	  Evaporation	  was	  not	  observed	  at	  any	  point,	  and	  control	  179	  
samples	  without	  enzyme,	  or	  with	  lysates	  from	  non-­‐TK	  expressing	  E.	  coli	  strains	  retained	  the	  initial	  180	  
substrate	  concentrations	  throughout.	  The	  TK	  concentration	  in	  each	  reaction	  was	  between	  0.07	  and	  181	  
0.3	  mg/ml.	  Higher	  TK	  concentrations	  were	  used	  for	  the	  3-­‐HBA	  reaction	  due	  to	  the	  slower	  conversion.	  182	  
All	  data	  were	  fitted	  by	  non-­‐linear	  regression	  to	  the	  Michaelis-­‐Menten	  equation	  to	  determine	  the	  KM	  183	  
and	  kcat	  of	  all	  the	  variants	  with	  each	  substrate.	  Double-­‐reciprocal	  Lineweaver-­‐Burk	  plots	  were	  also	  184	  
used	  to	  verify	  that	  the	  relationships	  between	  the	  velocity	  and	  the	  concentration	  were	  linear.	  The	  185	  
racemic	  products	  from	  3-­‐HBA	  [33],	  3-­‐FBA	  and	  4-­‐FBA	  [37]	  were	  synthesised,	  purified,	  and	  186	  
characterised	  as	  previously,	  as	  standards	  for	  HPLC	  calibration.	  	  None	  of	  the	  aromatic	  product	  187	  
enantiomers	  could	  be	  directly	  resolved	  by	  chiral-­‐HPLC	  and	  so	  derivatisation	  was	  attempted	  using	  188	  
several	  methods.	  Only	  3-­‐FBA	  could	  be	  derivatised	  with	  any	  success	  by	  dibenzoylation,	  but	  a	  189	  
significant	  degree	  of	  rearrangement	  via	  enolisation	  was	  noted,	  suggesting	  racemisation	  of	  the	  190	  
product	  occurred.	  This	  means	  that	  all	  e.e.	  values	  were	  probably	  underestimated.	  191	  
	  192	  
2.6. Computational	  docking	  of	  3-­‐FBA,	  4-­‐FBA	  and	  3-­‐HBA	  in	  transketolase	  variant	  active-­‐sites	  193	  
The	  structures	  of	  TK	  variants,	  aldehydes	  and	  ThDP	  enamine	  were	  modelled	  as	  previously	  194	  
described	  [33]	  (see	  SI	  for	  further	  details)	  into	  TK	  variant	  structures	  prepared	  by	  replacing	  the	  target	  195	  
10	  
	  
residues	  of	  the	  E.	  coli	  wild	  type	  (PDB	  ID:	  1QGD)	  [46].	  	  We	  define	  “productive	  location/proximity”	  in	  196	  
all	  cases	  simply	  as	  placing	  the	  aldehyde	  carbonyl	  and	  the	  enamine-­‐cofactor	  intermediate	  at	  within	  197	  
ca.	  5	  Å,	  provided	  that	  further	  rotation	  of	  the	  carbonyl	  is	  possible	  to	  achieve	  a	  suitable	  pi-­‐stacking	  198	  
trajectory	  for	  reaction.	  This	  simplification	  reflects	  the	  general	  expectations	  of	  using	  such	  a	  modelling	  199	  
method.	  200	  
	  201	  
3. Results	  and	  discussion	  202	  
	  203	  
3.1. Library	  screening	  204	  
3.1.1. Screening	  of	  the	  S385X/D469T/R520Q	  library	  205	  
	   Saturation	  mutagenesis	  of	  S385	  in	  wild-­‐type	  E.	  coli	  TK	  was	  found	  previously	  to	  give	  no	  206	  
variants	  with	  improved	  activity	  towards	  the	  aliphatic	  substrates	  glycolaldehyde	  or	  propanal	  [31,	  43].	  207	  
By	  contrast,	  the	  present	  screen	  of	  the	  S385X/D469T/R520Q	  library	  gave	  at	  least	  five	  unique	  variants	  208	  
with	  markedly	  improved	  (2-­‐5.5	  fold)	  conversion	  of	  3-­‐HBA	  after	  18	  hours	  (relative	  to	  D469T),	  and	  two	  209	  
variants	  with	  2-­‐2.5	  fold	  improved	  conversion	  of	  4-­‐FBA	  after	  18	  hours.	  	  One	  variant	  with	  only	  210	  
modestly	  improved	  (1.8	  fold)	  conversion	  of	  3-­‐FBA	  after	  1	  hour	  (Fig.	  1)	  was	  also	  obtained.	  Most	  other	  211	  
variants	  lowered	  or	  maintained	  the	  conversion	  of	  3-­‐FBA	  after	  1	  hour.	  	  Strikingly,	  the	  conversions	  at	  212	  
18	  hours	  from	  3-­‐HBA	  were	  highly	  correlated	  with	  those	  from	  4-­‐FBA,	  and	  to	  a	  lesser	  degree	  with	  213	  
conversions	  at	  1	  hour	  for	  3-­‐FBA.	  	  This	  suggested	  the	  same	  mechanism	  by	  which	  S385	  mutants	  214	  
improved	  the	  3-­‐HBA	  and	  4-­‐FBA	  reactions.	  	  Improvements	  for	  3-­‐FBA	  appear	  to	  arise	  through	  different	  215	  




Fig.	  1.	  Pairwise	  comparisons	  of	  activities	  for	  the	  S385X/D469T/R520Q	  library.	  Activity	  on	  3-­‐FBA	  was	  measured	  from	  the	  218	  
conversion	  after	  1	  hour,	  where	  the	  reactions	  were	  less	  than	  35%	  complete.	  	  Conversion	  at	  18	  hours	  gave	  an	  indirect	  219	  
measure	  of	  activity	  with	  slower	  4-­‐FBA	  and	  3-­‐HBA	  reactions.	  All	  reactions	  were	  performed	  using	  freshly	  harvested	  whole	  220	  
cells	  on	  50	  mM	  3-­‐FBA	  and	  50	  mM	  HPA,	  40	  mM	  4-­‐FBA	  and	  40	  mM	  HPA,	  or	  15	  mM	  3-­‐HBA	  and	  30	  mM	  HPA,	  each	  with	  221	  
2.4	  mM	  ThDP	  and	  9	  mM	  MgCl2	  in	  50	  mM	  Tris.HCl,	  pH	  7.0,	  at	  22	  °C	  with	  shaking	  at	  200	  rpm.	  Letters	  denote	  amino-­‐acid	  222	  
substitutions	  observed	  at	  X	  in	  S385X/D469T/R520Q.	  	  D469T	  refers	  to	  the	  parent	  variant	  D469T/R520Q.	  223	  
	  224	  
	   Specific	  activities	  of	  selected	  TK	  variants	  in	  clarified	  lysates	  were	  obtained	  for	  a	  more	  225	  
detailed	  and	  accurate	  comparison.	  D469T	  had	  a	  specific	  activity	  on	  3-­‐HBA	  of	  only	  226	  
0.0071	  μmol/mg/min,	  and	  a	  conversion	  to	  product	  of	  only	  7%	  after	  18	  hours	  (Table	  1).	  By	  contrast,	  227	  
the	  S385V/D469T/R520Q,	  S385Y/D469T/R520Q	  and	  S385T/D469T/R520Q	  variants	  achieved	  15%,	  228	  
25%,	  and	  31%	  conversion,	  respectively.	  Their	  specific	  activities	  also	  increased	  proportionally,	  229	  
between	  6-­‐	  and	  13-­‐fold,	  to	  0.03,	  0.071	  and	  0.073	  μmol/mg/min,	  respectively	  (see	  supplementary	  230	  
information,	  Fig.	  S3).	  The	  same	  correlation	  between	  specific	  activity	  and	  conversion	  after	  18	  hours	  231	  
was	  also	  observed	  for	  4-­‐FBA	  (Table	  1).	  This	  correlation	  has	  been	  previously	  observed	  to	  result	  from	  232	  
competition	  against	  HPA	  substrate	  degradation	  for	  the	  slower	  reactions	  of	  4-­‐FBA	  and	  3-­‐HBA	  [37],	  233	  
rather	  than	  due	  to	  an	  incomplete	  reaction	  at	  18	  hours,	  or	  enzyme	  instability	  over	  the	  18-­‐hour	  234	  
reaction	  period.	  Indeed,	  enzyme	  activity	  typic	  ally	  decreased	  by	  less	  than	  50%	  over	  18	  hours	  in	  the	  235	  
presence	  of	  aldehyde	  (see	  Fig.	  S4).	  	  For	  3-­‐FBA,	  the	  only	  variant	  with	  a	  higher	  (1.8-­‐fold)	  activity	  in	  the	  236	  
whole-­‐cell	  screen	  was	  S385E/D469T/R520Q.	  	  Using	  clarified	  lysate,	  this	  variant	  gave	  a	  3.5-­‐fold	  237	  
increase	  in	  specific	  activity	  with	  3-­‐FBA	  relative	  to	  that	  of	  D469T.	  The	  final	  conversion	  obtained	  with	  238	  
12	  
	  
3-­‐FBA	  for	  all	  variants,	  which	  did	  not	  increase	  beyond	  18	  hours,	  was	  between	  53%	  and	  67%	  indicating	  239	  
a	  persistent	  product	  inhibition.	  240	  
	   Most	  of	  the	  beneficial	  mutations	  (except	  S385E)	  introduced	  hydrophobic	  (A,	  V,	  Y)	  or	  polar	  (T)	  241	  
side	  chains,	  implicating	  modified	  hydrophobic	  interactions	  with	  each	  of	  the	  aromatic	  substrates,	  242	  
rather	  than	  affecting	  any	  specific	  interactions	  to	  the	  hydroxyl	  group	  of	  3-­‐HBA	  or	  the	  carboxylate	  243	  
moieties	  of	  4-­‐FBA	  or	  3-­‐FBA.	  This	  was	  slightly	  unexpected	  given	  that	  S385	  interacts	  with	  the	  244	  
phosphate	  group	  in	  natural	  sugar	  substrates.	  	  S385	  is	  in	  one	  of	  the	  two	  cofactor-­‐binding	  loops	  245	  
present	  within	  each	  active	  site.	  	  While	  the	  B-­‐factor	  of	  this	  residue	  and	  the	  neighbouring	  loop	  246	  
residues	  are	  not	  significantly	  higher	  than	  the	  average	  B-­‐factor	  for	  the	  structure	  (from	  PDB	  ID:	  1QGD)	  247	  
[46],	  an	  impact	  on	  KM	  or	  even	  kcat	  due	  to	  alteration	  of	  loop	  mobility	  upon	  mutation	  of	  S385	  cannot	  248	  
be	  ruled	  out.	  249	  
	  250	  
3.1.2. Screening	  of	  the	  R358X/D469T/R520Q	  library	  251	  
Saturation	  mutagenesis	  of	  R358	  in	  wild-­‐type	  E.	  coli	  TK	  previously	  led	  to	  only	  one	  beneficial	  252	  
variant	  R358I,	  which	  gave	  only	  a	  2-­‐fold	  improvement	  in	  the	  activity	  towards	  the	  aliphatic	  aldehydes	  253	  
glycolaldehyde	  and	  propanal	  [31,	  43].	  Some	  triple	  variants	  of	  R358X/D469T/R520Q,	  constructed	  and	  254	  
tested	  individually	  (data	  not	  shown),	  gave	  slightly	  reduced	  (R358H,	  and	  R358I)	  or	  severely	  255	  
diminished	  (R358E,	  R358Q)	  activities	  towards	  3-­‐FBA.	  The	  R358X/D469T/R520Q	  library	  provided	  no	  256	  
variants	  with	  improved	  activity	  towards	  any	  of	  the	  three	  aromatic	  substrates	  (Fig.	  2).	  	  This	  is	  not	  257	  
surprising	  for	  3-­‐FBA	  and	  4-­‐FBA,	  as	  we	  had	  previously	  identified	  charge	  stabilising	  interactions	  258	  
between	  their	  carboxylate	  moieties	  and	  R358	  [37].	  The	  initial	  library	  screen	  revealed	  that	  the	  259	  
conversions	  of	  3-­‐FBA	  and	  4-­‐FBA	  for	  all	  variants	  were	  highly	  correlated,	  and	  that	  most	  gave	  less	  than	  260	  
50%	  of	  the	  activity	  observed	  for	  D469T	  towards	  3-­‐FBA	  and	  4-­‐FBA.	  	  This	  is	  consistent	  with	  a	  common	  261	  
mechanism,	  in	  which	  each	  mutant	  affects	  similarly,	  the	  stabilising	  electrostatic	  interactions	  between	  262	  
R358	  and	  3-­‐FBA	  and	  4-­‐FBA.	  	  By	  contrast,	  half	  of	  the	  variants	  retained	  an	  activity	  towards	  3-­‐HBA	  263	  
similar	  to	  that	  obtained	  with	  D469T.	  The	  conversions	  of	  3-­‐FBA	  and	  4-­‐FBA	  for	  all	  variants	  were	  also	  264	  
13	  
	  
not	  well	  correlated	  to	  those	  of	  3-­‐HBA.	  This	  suggested	  that	  removing	  the	  positively	  charged	  R358	  265	  
side-­‐chain	  was	  not	  as	  detrimental	  for	  activity	  towards	  3-­‐HBA	  as	  it	  was	  for	  3-­‐FBA	  or	  4-­‐FBA.	  However,	  266	  
the	  lack	  of	  any	  improved	  R358	  variants	  towards	  3-­‐HBA	  was	  still	  surprising,	  as	  new	  favourable	  267	  
interactions	  with	  the	  uncharged	  hydroxyl	  moiety	  of	  3-­‐HBA	  might	  be	  expected.	  268	  
A	  few	  variants,	  R358T	  in	  particular,	  maintained	  at	  least	  60%	  of	  the	  activity	  to	  3-­‐FBA	  and	  4-­‐269	  
FBA.	  By	  contrast,	  R358T	  significantly	  reduced	  the	  activity	  towards	  3-­‐HBA,	  which	  was	  particularly	  270	  
unexpected	  given	  the	  potential	  to	  form	  a	  new	  hydrogen	  bond	  to	  this	  substrate.	  Conversely,	  3-­‐HBA	  271	  
tolerated	  a	  histidine	  residue,	  whereas	  the	  negatively	  charged	  4-­‐FBA	  and	  3-­‐FBA	  did	  not.	  This	  suggests	  272	  
that	  the	  hydroxyl	  moiety	  of	  bound	  3-­‐HBA	  might	  not	  be	  oriented	  towards	  R358	  in	  the	  same	  way	  as	  273	  
the	  carboxylate	  moieties	  of	  3-­‐FBA	  and	  4-­‐FBA.	  274	  
	  275	  
Fig.	  2.	  Pairwise	  comparisons	  of	  activities	  for	  the	  R358X/D469T/R520Q	  library.	  Activity	  on	  3-­‐FBA	  was	  measured	  from	  the	  276	  
conversion	  after	  1	  hour,	  where	  the	  reactions	  were	  less	  than	  35%	  complete.	  	  Conversion	  at	  18	  hours	  gave	  an	  indirect	  277	  
measure	  of	  activity	  with	  slower	  4-­‐FBA	  and	  3-­‐HBA	  reactions.	  	  All	  reactions	  were	  performed	  using	  freshly	  harvested	  whole	  278	  
cells	  on	  50	  mM	  3-­‐FBA	  and	  50	  mM	  HPA,	  40	  mM	  4-­‐FBA	  and	  40	  mM	  HPA,	  or	  15	  mM	  3-­‐HBA	  and	  30	  mM	  HPA,	  each	  with	  279	  
2.4	  mM	  ThDP	  and	  9	  mM	  MgCl2	  in	  50	  mM	  Tris.HCl,	  pH	  7.0,	  at	  22	  °C	  with	  shaking	  at	  200	  rpm.	  Letters	  denote	  amino-­‐acid	  280	  
substitutions	  observed	  at	  X	  in	  R358X/D469T/R520Q.	  	  D469T	  refers	  to	  the	  parent	  variant	  D469T/R520Q.	  281	  
	  282	  
Overall,	  the	  S385X	  library	  appeared	  to	  be	  more	  tolerant	  to	  different	  mutations	  than	  the	  R358X	  283	  
library	  when	  screening	  against	  3-­‐FBA	  and	  4-­‐FBA.	  	  However,	  the	  R358	  residue	  was	  tolerant	  to	  most	  284	  
mutations	  with	  the	  activity	  on	  3-­‐HBA.	  	  It	  appeared	  then	  that	  the	  interactions	  between	  natural	  TK	  285	  
substrates	  and	  residue	  S385	  were	  no	  longer	  critical	  or	  present	  with	  the	  acidic	  aromatic-­‐aldehyde	  286	  
14	  
	  
substrates	  3-­‐FBA	  and	  4-­‐FBA,	  whereas	  the	  charge-­‐charge	  interactions	  with	  R358,	  as	  determined	  287	  
previously	  [37],	  were	  still	  important	  to	  retain.	  288	  
	  289	  
3.2. Kinetic	  parameters	  of	  the	  variants	  with	  3-­‐FBA,	  4-­‐FBA,	  and	  3-­‐HBA	  290	  
	   Any	  variant	  with	  improved	  activity	  towards	  at	  least	  one	  substrate	  was	  assessed	  in	  more	  291	  
detail	  with	  all	  three	  substrates	  to	  understand	  whether	  any	  shifts	  in	  specificity	  were	  due	  to	  the	  loss	  of	  292	  
affinity	  or	  increased	  catalytic	  efficiency	  (kcat).	  All	  kinetic	  parameters	  are	  summarised	  in	  Table	  1.	  293	  
S385E/D469T/R520Q	  gave	  a	  3.5-­‐fold	  increase	  in	  specific	  activity	  with	  3-­‐FBA	  relative	  to	  that	  of	  D469T,	  294	  
and	  it	  was	  found	  to	  significantly	  increase	  the	  kcat	  to	  34.3±	  1.6	  s-­‐1,	  which	  was	  2.6	  times	  greater	  than	  295	  
that	  for	  D469T.	  Furthermore,	  the	  KM	  decreased	  to	  18.3	  ±	  2.6	  mM,	  which	  was	  3-­‐fold	  lower	  than	  that	  296	  
for	  D469T,	  although	  most	  of	  this	  substrate	  binding	  effect	  was	  already	  achieved	  in	  with	  the	  R520Q	  297	  
mutation	  in	  D469T/R520Q.	  Therefore,	  most	  of	  the	  beneficial	  effect	  of	  the	  S385E	  mutation	  was	  due	  298	  
to	  an	  increase	  in	  kcat.	  The	  KM	  achieved	  was	  also	  lower	  than	  the	  55	  mM	  previously	  determined	  for	  299	  
D469T	  with	  propanal	  [31],	  and	  lower	  than	  the	  24.5	  mM	  KM	  for	  the	  well-­‐characterised	  glycolaldehyde	  300	  
substrate	  and	  wild-­‐type	  E.	  coli	  TK	  [37].	  The	  kcat/KM	  of	  S385E/D469T/R520Q	  was	  increased	  to	  301	  
1900±270	  s-­‐1	  M-­‐1,	  a	  4-­‐fold	  improvement	  over	  D469T/R520Q,	  and	  a	  9-­‐fold	  increase	  over	  D469T.	  302	  
Surprisingly,	  the	  substrate	  inhibition	  observed	  previously	  in	  all	  TK	  variants	  with	  3-­‐FBA	  [37],	  was	  also	  303	  
completely	  removed.	  No	  inhibition	  was	  observed	  up	  to	  the	  maximum	  concentration	  tested	  of	  304	  
90	  mM	  3-­‐FBA.	  305	  
	   The	  specific	  activity	  of	  S385E/D469T/R520Q	  towards	  3-­‐HBA	  was	  also	  improved	  6-­‐fold	  306	  
relative	  to	  D469T,	  although	  a	  KM	  of	  245	  mM	  and	  kcat	  of	  0.59	  s-­‐1	  indicated	  that	  this	  activity	  was	  still	  307	  
relatively	  modest.	  The	  low	  activities	  made	  it	  too	  difficult	  to	  obtain	  kinetic	  parameters	  for	  D469T	  and	  308	  
D469T/R520Q.	  Interestingly,	  the	  same	  variant	  lost	  80%	  of	  the	  specific	  activity	  towards	  4-­‐FBA	  relative	  309	  
to	  that	  of	  D469T.	  In	  fact,	  the	  KM	  (72	  ±	  30	  mM)	  for	  4-­‐FBA	  improved	  3.5-­‐fold	  relative	  to	  that	  with	  310	  
D469T,	  but	  increased	  3-­‐fold	  relative	  to	  that	  with	  D469T/R520Q.	  However,	  the	  kcat	  was	  16-­‐fold	  lower	  311	  
than	  for	  D469T,	  and	  only	  marginally	  improved	  relative	  to	  D469T/R520Q.	  312	  
15	  
	  
	   It	  is	  interesting	  that	  S385E	  significantly	  increases	  the	  kcat	  for	  3-­‐FBA,	  but	  has	  no	  effect	  on	  the	  313	  
kcat	  for	  4-­‐FBA.	  This	  suggests	  that	  kcat	  for	  aromatic	  aldehyde	  substrates	  is	  dependent	  on	  the	  aromatic	  314	  
substitution	  type	  and	  position,	  and	  is	  not	  a	  general	  catalytic	  effect	  of	  the	  enzyme	  for	  all	  substrates.	  315	  
Indeed	  kcat	  can	  be	  affected	  by	  substrate	  orientation	  and	  proximity	  to	  the	  cofactor	  and	  catalytic	  316	  
residues.	  The	  data	  suggest	  that	  while	  the	  carboxylate	  moieties	  of	  3-­‐FBA	  and	  4-­‐FBA	  both	  interact	  with	  317	  
R358,	  the	  reactive	  aldehyde	  moieties	  are	  oriented	  differently	  in	  the	  active	  site	  due	  to	  the	  different	  318	  
spatial	  constraints	  of	  the	  two	  molecules,	  giving	  rise	  to	  their	  respective	  kcat	  values.	  S385	  mutations	  319	  
appear	  to	  influence	  this	  molecular	  orientation	  and	  hence	  kcat.	  While	  electronic	  effects	  on	  the	  320	  
aldehyde	  moiety,	  due	  to	  different	  positions	  of	  the	  aromatic	  substitutions	  in	  3-­‐FBA	  and	  4-­‐FBA,	  may	  321	  
also	  potentially	  play	  a	  role,	  this	  appears	  to	  be	  a	  minor	  factor	  as	  4-­‐FBA	  would	  be	  expected	  to	  have	  322	  
greater	  reactivity	  than	  3-­‐FBA	  based	  on	  electronic	  effects	  alone.	  323	  
The	  highest	  values	  of	  kcat/KM	  were	  found	  for	  S385Y/D469T/R520Q	  and	  S385T/D469T/R520Q	  324	  
towards	  3-­‐FBA	  (Table	  1).	  Most	  of	  this	  improvement	  was	  due	  to	  an	  almost	  10-­‐fold	  decrease	  in	  KM	  325	  
relative	  to	  D469T/R520Q,	  to	  the	  lowest	  value	  for	  all	  variant-­‐substrate	  combinations	  of	  just	  1.3	  mM	  326	  
3-­‐FBA.	  Notably,	  this	  KM	  value	  is	  comparable	  to	  those	  of	  the	  natural	  TK	  substrates,	  which	  range	  from	  327	  
2.1	  mM	  on	  D-­‐glyceraldehyde-­‐3-­‐phosphate,	  down	  to	  0.008	  mM	  on	  D-­‐Ribose-­‐5-­‐phosphate	  [14].	  328	  
However,	  the	  activities	  of	  the	  S385Y/D469T/R520Q	  and	  S385T/D469T/R520Q	  variants	  towards	  3-­‐FBA	  329	  
were	  significantly	  lower	  than	  most	  of	  the	  other	  variants,	  and	  only	  around	  50%	  of	  D469T.	  This	  was	  330	  
due	  to	  significant	  inhibition	  of	  both	  variants	  by	  3-­‐FBA	  at	  concentrations	  above	  20	  mM,	  which	  is	  in	  331	  
marked	  contrast	  to	  the	  removal	  of	  substrate	  inhibition	  by	  the	  S385E	  mutation.	  	  332	  
S385Y/D469T/R520Q	  and	  S385T/D46T/R520Q	  were	  also	  the	  only	  two	  variants	  to	  give	  at	  333	  
least	  40%	  greater	  conversion	  of	  4-­‐FBA	  during	  screening,	  than	  for	  D469T.	  Previously	  it	  was	  observed	  334	  
that	  the	  R520Q	  mutation	  in	  D469T/R520Q	  decreased	  the	  KM	  10-­‐fold,	  but	  unfortunately	  also	  335	  
decreased	  the	  kcat	  25-­‐fold	  with	  4-­‐FBA	  [37].	  The	  two	  triple	  variants	  S385Y/D469T/R520Q	  and	  336	  
S385T/D469T/R520Q	  retained	  similar	  affinities	  towards	  4-­‐FBA	  as	  for	  D469T/R520Q,	  but	  their	  kcat	  337	  
values	  were	  considerably	  improved.	  The	  restored	  kcat	  and	  good	  substrate	  affinities	  of	  these	  two	  338	  
16	  
	  
variants	  resulted	  in	  a	  dramatic	  increase	  in	  their	  activities	  towards	  4-­‐FBA,	  a	  4.5-­‐5	  fold	  improvement	  in	  339	  
kcat/KM	  relative	  to	  that	  of	  D469T,	  and	  over	  10-­‐fold	  improvement	  in	  kcat/KM	  compared	  to	  340	  
D469T/R520Q.	  The	  latter	  is	  attributable	  to	  the	  effect	  of	  the	  S385Y	  and	  S385T	  mutations	  upon	  kcat	  341	  
alone.	  342	  
S385Y/D469T/R520Q	  and	  S385T/D469T/R520Q	  were	  also	  found	  to	  have	  greater	  activities	  343	  
towards	  3-­‐HBA	  compared	  to	  D469T.	  The	  kcat	  and	  KM	  values	  for	  3-­‐HBA	  could	  not	  be	  readily	  obtained	  344	  
for	  D469T	  or	  D469T/R520Q	  due	  to	  low	  activities.	  The	  kcat	  values	  obtained	  for	  S385Y/D469T/R520Q	  345	  
and	  S385T/D469T/R520Q	  with	  3-­‐HBA	  were	  2.1	  and	  1.0	  s-­‐1	  respectively,	  which	  were	  similar	  to	  those	  346	  
for	  4-­‐FBA	  but	  3	  to	  4	  fold	  lower	  than	  those	  for	  3-­‐FBA.	  Furthermore,	  their	  KM	  values	  were	  100-­‐300	  347	  
times	  higher	  than	  those	  for	  3-­‐FBA,	  and	  8-­‐25	  fold	  higher	  than	  for	  4-­‐FBA.	  Therefore,	  their	  kcat/KM	  348	  
values	  were	  up	  to	  1000	  times	  lower	  than	  for	  S385Y/D469T/R520Q	  with	  3-­‐FBA.	  349	  
These	  data	  support	  our	  previous	  hypothesis	  that	  enzyme-­‐substrate	  affinity	  and	  positioning	  350	  
of	  the	  substrate	  are	  competing	  major	  factors	  to	  be	  overcome	  when	  attempting	  to	  improve	  the	  351	  
bioconversion	  rate	  of	  poorly	  accepted	  aromatic	  aldehydes	  in	  transketolase	  [37].	  The	  specific	  352	  
activities	  of	  all	  variants	  towards	  3-­‐HBA	  are	  significantly	  lower	  than	  with	  3-­‐FBA	  or	  4-­‐FBA,	  as	  their	  KM	  353	  
values	  are	  all	  still	  much	  higher	  than	  the	  substrate	  concentration.	  However,	  different	  kcat	  effects	  354	  
observed	  suggest	  positioning	  of	  the	  substrate	  relative	  to	  catalytic	  groups	  can	  have	  a	  significant	  355	  
impact.	  This	  underlies	  the	  different	  shifts	  in	  substrate	  preference	  for	  the	  S385E	  mutation	  within	  356	  
D469T/R520Q	  compared	  to	  those	  of	  S385Y	  and	  S385T.	  S385E	  mostly	  improved	  the	  kcat	  towards	  3-­‐357	  
FBA,	  whereas	  for	  4-­‐FBA	  the	  greatest	  impact	  was	  an	  increase	  in	  KM.	  S385Y	  and	  S385T	  both	  improved	  358	  
the	  KM	  for	  3-­‐FBA,	  and	  yet	  increased	  the	  kcat	  towards	  4-­‐FBA.	  This	  suggests	  that	  the	  position	  of	  the	  359	  
substrate	  relative	  to	  the	  catalytic	  groups	  is	  very	  sensitive	  to	  mutation,	  and	  that	  while	  3-­‐FBA	  and	  360	  
4-­‐FBA	  are	  have	  favourable	  electrostatic	  interactions	  to	  R358,	  they	  orient	  the	  aldehyde	  moiety	  361	  
differently	  towards	  the	  active-­‐site	  cofactor.	  This	  presumably	  reflects	  the	  different	  relative	  positions	  362	  

















D469T	   3-­‐FBA	   1.0a	   67	  (1.0)	   56	  (10)b	   13.2	  (1.5)	   240	  (50)	  
D469T/R520Q	   3-­‐FBA	   0.8	   67	  (0.1)	   13	  (4)b	   6.0	  (0.75)	   470	  (170)	  
S385E/D469T/R520Q	   3-­‐FBA	   3.5	   63	  (1.0)	   18(3)	   34	  (1.6)	   1900	  (270)	  
S385Y/D469T/R520Q	   3-­‐FBA	   0.5	   53	  (0.8)	   1.3	  (0.4)	   7.0	  (0.3)	   5400	  (1490)	  
S385T/D469T/R520Q	   3-­‐FBA	   0.5	   59	  (0.5)	   1.7	  (0.25)	   7.3	  (0.2)	   4250	  (620)	  
	   	   	   	   	   	   	  
D469T	   4-­‐FBA	   1.0a	   30	  (1.7)	   251	  (240)b	   5.0	  (4.4)	   20	  (26)	  
D469T/R520Q	   4-­‐FBA	   0.5	   13	  (0.4)	   25	  (8)b	   0.20	  (0.03)	   8.1	  (2.8)	  
S385E/D469T/R520Q	   4-­‐FBA	   0.2	   <5	   72	  (30)	   0.3	  (0.1)	   4.6	  (2.4)	  
S385Y/D469T/R520Q	   4-­‐FBA	   3.4	   48	  (0.4)	   15	  (3)	   1.7	  (0.1)	   110	  (21)	  
S385T/D469T/R520Q	   4-­‐FBA	   2.1	   48	  (1.7)	   23	  (6)	   2.1	  (0.3)	   90	  (26)	  
	   	   	   	   	   	   	  
D469T	   3-­‐HBA	   1.0a	   7	   n.d.c	   n.d.	   n.d.	  
D469T/R520Q	   3-­‐HBA	   n.d.	   6	   n.d.	   n.d.	   n.d.	  
S385E/D469T/R520Q	   3-­‐HBA	   6.0	   15	  (1)	   245	  (15)	   0.6	  (0.1)	   2.4	  (0.2)	  
S385Y/D469T/R520Q	   3-­‐HBA	   12.4	   25	  (1)	   390	  (10)	   2.1	  (0.2)	   5.4	  (0.1)	  
S385T/D469T/R520Q	   3-­‐HBA	   12.7	   31	  (2)	   180	  (10)	   1.0	  (0.1)	   5.5	  (0.2)	  
Table	  1.The	  kinetic	  parameters	  of	  all	  the	  variants	  towards	  3-­‐FBA,	  4-­‐FBA	  and	  3-­‐HBA.	  a	  Specific	  activities	  of	  D469T	  at	  50	  mM	  365	  
3-­‐FBA/50	  mM	  HPA,	  30	  mM	  4-­‐FBA/50	  mM	  HPA	  and	  15	  mM	  3-­‐HBA/	  30	  mM	  HPA	  were	  4.63	  μmol/mg/min,	  366	  
0.45	  μmol/mg/min,	  and	  0.0071	  μmol/mg/min,	  respectively.	  b	  The	  kinetic	  data	  of	  D469T	  and	  D469T/R520Q	  were	  from	  [37].	  367	  
c	  Values	  were	  not	  determined	  (n.d.)	  due	  to	  very	  low	  activity.	  Standard	  deviations	  are	  given	  in	  parentheses.	  	  All	  mutants	  368	  
have	  been	  determined	  to	  achieve	  e.e.s	  in	  the	  range	  45-­‐62%	  with	  3-­‐FBA,	  but	  due	  to	  partial	  product	  racemization	  in	  the	  369	  




3.3. Computational	  modelling	  of	  S385E/Y/D469T/R520Q	  structures	  and	  substrate	  binding	  372	  
The	  shifts	  in	  kcat	  are	  not	  the	  same	  for	  all	  three	  substrates,	  suggesting	  that	  they	  are	  due	  to	  373	  
modified	  binding	  orientation	  or	  proximity	  to	  the	  catalytic	  residues,	  rather	  than	  general	  effects	  on	  374	  
catalytic	  enzyme	  residues	  or	  the	  cofactors.	  	  For	  3-­‐HBA,	  the	  proximity	  to	  R358	  also	  appears	  to	  be	  less	  375	  
important	  than	  that	  of	  3-­‐FBA	  and	  4-­‐FBA.	  	  Computational	  modelling	  was	  used	  to	  begin	  to	  rationalise	  376	  
these	  observations	  structurally,	  and	  provide	  testable	  hypotheses	  for	  future	  structural	  studies.	  	  We	  377	  
have	  previously	  used	  the	  same	  approach	  with	  transketolase,	  and	  shown	  that	  it	  predicts	  378	  
experimental	  KM	  values	  with	  an	  R2	  of	  0.82	  [37],	  partly	  because	  the	  active-­‐site	  residues	  do	  not	  move	  379	  
significantly	  upon	  binding	  of	  substrates.	  	  This	  approach	  was	  therefore	  shown	  to	  be	  effective	  at	  380	  
rationalising	  the	  effect	  of	  TK	  mutations	  on	  various	  substrates	  and	  so	  was	  used	  here	  to	  extend	  the	  381	  
models	  to	  S385	  mutations	  within	  the	  previously	  modelled	  D469T/R520Q	  active-­‐site.	  382	  
3-­‐FBA	  was	  expected	  to	  bind	  in	  the	  S385E/D469T/R520Q	  active-­‐site	  in	  a	  rather	  different	  383	  
conformation	  than	  for	  D469T	  and	  D469T/R520Q.	  	  S385E/D469T/R520Q	  bound	  to	  3-­‐FBA	  was	  384	  
modelled	  in	  AUTODOCK	  and	  compared	  in	  Fig.	  3	  to	  those	  obtained	  previously	  for	  D469T	  and	  385	  
D469T/R520Q	  [37,	  39].	  	  Docking	  of	  3-­‐FBA	  in	  S385E/D469T/R520Q	  revealed	  two	  possible	  binding	  386	  
clusters,	  with	  different	  binding	  energies	  and	  populations	  (Fig.	  3a).	  	  The	  first	  binding	  cluster	  had	  a	  387	  
lower	  population	  (38%)	  than	  the	  second	  (62%),	  and	  resulted	  from	  interactions	  between	  R358	  and	  388	  
H461,	  and	  the	  carboxylate	  moiety	  on	  3-­‐FBA.	  	  It	  was	  the	  only	  binding	  cluster	  found	  previously	  in	  the	  389	  
models	  for	  D469T	  (Fig.	  3b)	  and	  D469T/R520Q	  (Fig.	  3c).	  	  However,	  this	  cluster	  is	  poorly	  oriented	  for	  390	  
catalysis	  with	  the	  aldehyde	  at	  5-­‐7	  Å	  away	  from	  the	  cofactor-­‐enamine	  intermediate.	  	  The	  second	  391	  
cluster	  appeared	  only	  with	  S385E/D469T/R520Q,	  and	  placed	  the	  aldehyde	  in	  a	  more	  catalytically	  392	  
productive	  location.	  	  Interestingly,	  the	  3-­‐FBA	  in	  this	  cluster	  was	  bound	  very	  differently,	  with	  no	  393	  
interaction	  between	  R358	  and	  the	  carboxylate	  moiety	  of	  3-­‐FBA.	  	  The	  carboxylate	  moiety	  of	  3-­‐FBA	  394	  
instead	  formed	  hydrogen	  bonds	  with	  the	  side-­‐chains	  of	  R91	  and	  H26,	  and	  with	  the	  backbone	  NH	  of	  395	  
G25.	  	  The	  aldehyde	  was	  held	  in	  place	  by	  forming	  hydrogen	  bonds	  with	  H26	  and	  H261,	  placing	  the	  396	  
aldehyde	  4.6	  Å	  away	  from	  the	  reactive	  enamine	  intermediate.	  	  This	  distance	  is	  slightly	  shorter	  than	  397	  
19	  
	  
the	  closest	  predicted	  previously	  with	  D469T	  (4.9Å)	  [37],	  and	  could	  contribute	  to	  the	  improved	  kcat	  398	  
observed	  experimentally.	  	  The	  new	  binding	  mode	  found	  only	  in	  S385E/D469T/R520Q	  could	  also	  399	  
potentially	  explain	  the	  alleviation	  of	  substrate	  inhibition.	  400	  
	  401	  
	  402	  
Fig.	  3.	  The	  computational	  docking	  of	  3-­‐FBA	  into	  a)	  S385E/D469T/R520Q,	  b)	  D469T,	  and	  c)	  D469T/R520Q	  active-­‐sites.	  For	  403	  
S385E/D469T/R520Q	  the	  first	  cluster	  is	  shown	  with	  white	  sticks,	  and	  the	  second	  cluster	  is	  shown	  with	  green	  sticks.	  For	  404	  
D469T	  and	  D469T/R520Q,	  the	  two	  conformations	  within	  the	  single	  identified	  cluster	  are	  shown	  with	  yellow	  (catalytically	  405	  
productive)	  and	  cyan	  (catalytically	  unproductive)	  sticks.	  Calculated	  hydrogen	  bonds	  are	  shown	  as	  black	  dotted	  lines.	  406	  
	  407	  
Computational	  docking	  was	  also	  used	  to	  investigate	  the	  significantly	  improved	  kcat	  found	  408	  
with	  the	  S385Y	  mutation	  in	  S385Y/D469T/R520Q	  for	  both	  4-­‐FBA	  and	  3-­‐HBA.	  	  Docking	  revealed	  only	  409	  
one	  binding	  cluster	  and	  conformation	  of	  4-­‐FBA	  in	  S385Y/D469T/R520Q	  (Fig.	  4a),	  which	  provides	  a	  410	  
possible	  entropic	  explanation	  for	  the	  improved	  kcat	  relative	  to	  that	  of	  D469T/R520Q,	  for	  which	  many	  411	  
clusters	  were	  predicted	  [37].	  	  Autodock	  also	  previously	  predicted	  a	  single	  binding	  cluster	  for	  4-­‐FBA	  in	  412	  
D469T	  [37],	  which	  has	  a	  3-­‐fold	  higher	  kcat	  than	  S385Y/D469T/R520Q	  (Table	  1).	  	  The	  distance	  from	  the	  413	  
enamine	  intermediate	  to	  the	  aldehyde	  in	  4-­‐FBA	  was	  predicted	  to	  be	  5	  Å	  in	  S385Y/D469T/R520Q,	  414	  
which	  is	  the	  same	  as	  for	  the	  closest	  conformer	  predicted	  with	  D469T	  [37].	  	  The	  predicted	  binding	  of	  415	  
4-­‐FBA	  in	  S385Y/D469T/R520Q	  also	  showed	  possible	  pi-­‐stacking	  between	  4-­‐FBA	  and	  the	  tyrosine	  ring	  416	  
of	  S385Y,	  along	  with	  hydrogen	  bonding	  /	  ionic	  interaction	  between	  the	  4-­‐FBA	  carboxylate	  moiety	  417	  
and	  R358.	  	  However,	  a	  similar	  Km	  to	  those	  of	  D469T/R520Q,	  S385T/D469T/R520Q	  and	  similar	  gains	  in	  418	  





Fig.	  4.	  The	  computational	  docking	  of	  a)	  4-­‐FBA	  and	  b)	  3-­‐HBA	  into	  the	  S385Y/D469T/R520Q	  active	  site.	  For	  4-­‐FBA	  a	  single	  422	  
docking	  cluster	  was	  observed	  (white	  sticks).	  For	  3-­‐HBA	  two	  binding	  clusters	  were	  observed	  and	  shown	  in	  green	  sticks	  423	  
(catalytically	  productive)	  and	  yellow	  sticks	  (catalytically	  unproductive).	  Calculated	  hydrogen	  bonds	  are	  shown	  as	  black	  424	  
dotted	  lines.	  425	  
	  426	  
Computational	  docking	  was	  also	  used	  to	  investigate	  the	  similarities	  and	  differences	  between	  427	  
4-­‐FBA	  and	  3-­‐HBA	  activity	  in	  S385Y/D469T/R520Q	  (Figs.	  4a	  and	  4b).	  	  This	  variant	  improved	  the	  428	  
specific	  activity	  towards	  both	  4-­‐FBA	  and	  3-­‐HBA,	  but	  the	  activity	  towards	  3-­‐HBA	  was	  still	  much	  lower	  429	  
than	  for	  4-­‐FBA.	  	  The	  kcat	  values	  for	  4-­‐FBA	  and	  3-­‐HBA	  were	  similar	  but	  their	  KM	  values	  were	  at	  least	  430	  
20-­‐fold	  different.	  	  Consistent	  with	  this	  experimental	  observation,	  only	  two	  out	  of	  the	  four	  major	  431	  
docking	  clusters	  were	  found	  to	  be	  deep	  within	  the	  active	  site,	  and	  only	  one	  (highlighted	  in	  green	  in	  432	  
Fig.	  4b)	  was	  in	  a	  catalytically	  productive	  proximity,	  indicating	  a	  greater	  prevalence	  of	  non-­‐specific	  433	  
binding	  for	  3-­‐HBA	  relative	  to	  that	  of	  4-­‐FBA.	  	  3-­‐HBA	  did	  not	  form	  the	  pi-­‐stacking	  interaction	  with	  the	  434	  
new	  tyrosine	  ring	  in	  S385Y	  that	  was	  observed	  with	  4-­‐FBA.	  	  It	  is	  also	  not	  possible	  for	  3-­‐HBA	  to	  form	  435	  
any	  favourable	  electrostatic	  interaction	  with	  R358	  such	  as	  that	  observed	  with	  4-­‐FBA.	  	  The	  hydroxyl	  436	  
moiety	  of	  3-­‐HBA	  was	  found	  to	  hydrogen	  bond	  with	  the	  S385Y	  tyrosine	  side-­‐chain	  4-­‐hydroxyl	  group,	  437	  
but	  not	  with	  R358.	  	  This	  is	  consistent	  with	  the	  experimental	  data	  in	  which	  R358	  mutations	  did	  not	  438	  
21	  
	  
lead	  to	  improved	  activity	  towards	  3-­‐HBA,	  and	  also	  in	  particular	  why	  the	  R358T	  mutation	  was	  not	  439	  
beneficial.	  	  	  440	  
	  441	  
4.	  Conclusions	  442	  
Random	  mutation	  of	  one	  residue	  in	  the	  first	  shell	  of	  the	  transketolase	  active-­‐site	  was	  shown	  443	  
to	  improve	  the	  enzyme	  activity	  and	  yield	  towards	  both	  carboxylated	  and	  hydroxylated	  aromatic	  444	  
aldehyde	  substrates.	  	  Remarkably,	  these	  new	  TK	  variants	  gave	  KM	  values	  comparable	  to	  that	  found	  445	  
with	  wild-­‐type	  TK	  for	  the	  natural	  substrate	  glyceraldehyde-­‐3-­‐phosphate,	  and	  kcat/KM	  values	  of	  1900-­‐446	  
5400	  s-­‐1	  M-­‐1.	  	  The	  new	  TK	  activities,	  which	  generate	  aromatic	  dihydroxyketones,	  open	  up	  a	  novel	  447	  
route	  to	  chloramphenicol	  analogues	  via	  subsquent	  amination	  of	  the	  product	  ketone-­‐moieties,	  either	  448	  
chemically	  or	  using	  transaminases.	  	  Triple	  variants	  of	  TK	  were	  created	  with	  up	  to	  13-­‐fold	  greater	  449	  
activity	  than	  D469T	  towards	  aromatic	  aldehydes.	  	  The	  slow	  bioconversion	  of	  3-­‐HBA	  relative	  to	  the	  450	  
carboxylated	  substrates	  was	  predominantly	  due	  to	  a	  lower	  affinity	  between	  enzyme	  and	  substrate.	  451	  
Interestingly,	  a	  comparison	  of	  the	  kinetics	  for	  all	  variants	  towards	  the	  three	  aromatic	  substrates	  452	  
indicated	  that	  the	  binding	  modes	  for	  each	  substrate	  in	  their	  best	  respective	  variant	  are	  different,	  453	  
suggesting	  one	  mechanism	  by	  which	  natural	  enzyme	  specificities	  could	  diverge.	  	  For	  those	  aiming	  to	  454	  
evolve	  multiple	  substrate	  specificities	  using	  target	  libraries	  and	  substrate	  walking	  approaches	  [47],	  455	  
such	  divergence	  of	  substrate	  binding	  modes	  could	  have	  important	  implications	  for	  the	  choice	  of	  456	  
directed	  evolution	  strategies	  in	  subsequent	  steps,	  as	  different	  substrates	  may	  require	  distinctly	  457	  
different	  libraries	  to	  be	  screened.	  	  Computational	  docking	  was	  able	  to	  rationalise	  the	  different	  458	  
behaviours	  for	  the	  three	  substrates	  in	  terms	  of	  their	  different	  response	  to	  mutations	  upon	  kcat,	  KM	  459	  
and	  substrate	  inhibition,	  and	  supported	  the	  hypothesis	  for	  divergent	  binding	  modes	  that	  could	  be	  460	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